Yüklüyor......

Ertugliflozin in the treatment of type 2 diabetes mellitus

More than 422 million people worldwide have diabetes, with 90–95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in microvascular complications but recent data have demonstrated improvements in macrovascular outcomes with sodium–glucose cotransporter 2 (SGLT2) inhi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drugs Context
Asıl Yazarlar: Marrs, Joel C, Anderson, Sarah L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioExcel Publishing Ltd 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7707814/
https://ncbi.nlm.nih.gov/pubmed/33293984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-7-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!